COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management.

Authors

Yasar Sattar, Icahn School of Medicine at Mount Sinai - Elmhurst Hospital
Waqas Ullah, Abington Jefferson Health
Medhat Chowdhury, Rochester Regional HealthFollow
Mohit Pahuja, Rochester Regional Health

Department

Internal Medicine

Document Type

Article

Publication Title

International Journal of Cardiology. Heart & Vasculature

Abstract

Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic that may present with a variety of cardiac manifestations including, but not limited to, myocardial injury, myocardial infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest. These cardiovascular effects are worse in patients who have pre-existing cardiac conditions such as coronary artery disease, hypertension, diabetes mellitus, and coagulation abnormalities. Other predisposing risk factors include advanced age, immunocompromised state, and underlying systemic inflammatory conditions. Here we review the cellular pathophysiology, clinical manifestations and treatment modalities of the cardiac manifestations seen in patients with COVID-19.

First Page

100589

Last Page

100589

DOI

10.1016/j.ijcha.2020.100589

Volume

29

Publication Date

8-1-2020

Comments

See full list of authors at journal website.

PubMed ID

32724831

Recommended Citation

Sattar, Y., Ullah, W., Chowdhury, M., & Pahuja, M. (2020). COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management.. International Journal of Cardiology. Heart & Vasculature, 29, 100589-100589. https://doi.org/10.1016/j.ijcha.2020.100589